ArticleTherapeutic advances in medical oncology2018

HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9.

Dong-Qin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.